|
Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
|
12/11/12
|
Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
|
PDF
|
|
Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
|
12/05/12
|
Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
|
PDF
|
|
Valeant Pharmaceuticals Announces New Management Appointments
|
11/28/12
|
Valeant Pharmaceuticals Announces New Management Appointments
|
PDF
|
|
Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
|
11/26/12
|
Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
|
PDF
|
|
Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
|
11/19/12
|
Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
|
PDF
|
|
Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
|
11/16/12
|
Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
|
PDF
|
|
Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
|
11/02/12
|
Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
|
09/03/12
|
Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
|
PDF
|
|
Valeant Pharmaceuticals Reports 2012 Second Quarter Financial Results
|
08/02/12
|
Valeant Pharmaceuticals Reports 2012 Second Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
|
07/16/12
|
Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
|
PDF
|
|
Valeant Pharmaceuticals to Host Investor Day
|
06/21/12
|
Valeant Pharmaceuticals to Host Investor Day
|
PDF
|
|
Valeant Pharmaceuticals Agrees To Acquire OraPharma
|
06/15/12
|
Valeant Pharmaceuticals Agrees To Acquire OraPharma
|
PDF
|
|
Valeant Pharmaceuticals Completes Syndication Of Incremental Term Loans
|
06/14/12
|
Valeant Pharmaceuticals Completes Syndication Of Incremental Term Loans
|
PDF
|
|
Valeant Pharmaceuticals To Host Investor Day
|
06/07/12
|
Valeant Pharmaceuticals To Host Investor Day
|
PDF
|
|
Valeant Pharmaceuticals To Syndicate Incremental Term Loans
|
05/30/12
|
Valeant Pharmaceuticals To Syndicate Incremental Term Loans
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
|
05/24/12
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
|
PDF
|
|
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
|
05/03/12
|
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
|
PDF
|
|
Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
|
05/03/12
|
Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals To Webcast 2012 Annual Meeting Of Shareholders
|
04/30/12
|
Valeant Pharmaceuticals To Webcast 2012 Annual Meeting Of Shareholders
|
PDF
|
|
Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
|
04/27/12
|
Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Atlantis Pharma in Mexico
|
04/18/12
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Atlantis Pharma in Mexico
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012
|
04/16/12
|
Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012
|
PDF
|
|
Valeant Pharmaceuticals to Acquire Pedinol
|
04/12/12
|
Valeant Pharmaceuticals to Acquire Pedinol
|
PDF
|
|
Valeant to Move Its Global Head Office to Quebec and Establish a New Center of Excellence in Dermatology
|
04/03/12
|
Valeant to Move Its Global Head Office to Quebec and Establish a New Center of Excellence in Dermatology
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia
|
03/26/12
|
Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets From Gerot Lannach
|
03/13/12
|
Valeant Pharmaceuticals Agrees to Acquire Certain Assets From Gerot Lannach
|
PDF
|
|
Valeant Pharmaceuticals Acquires a 19.9% Minority Equity Investment in Biotech Company in Brazil
|
03/12/12
|
Valeant Pharmaceuticals Acquires a 19.9% Minority Equity Investment in Biotech Company in Brazil
|
PDF
|
|
Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
|
02/27/12
|
Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals to Acquire Eyetech
|
02/13/12
|
Valeant Pharmaceuticals to Acquire Eyetech
|
PDF
|
|
Valeant Completes Syndication of Senior Secured Term Loan B Facility
|
02/13/12
|
Valeant Completes Syndication of Senior Secured Term Loan B Facility
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
|
02/08/12
|
Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012
|
PDF
|
|
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
|
02/06/12
|
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
|
PDF
|
|
Valeant Pharmaceuticals Acquires Probiotica in Brazil
|
02/01/12
|
Valeant Pharmaceuticals Acquires Probiotica in Brazil
|
PDF
|
|
Valeant Pharmaceuticals to Syndicate Senior Secured Term Loan Credit Facility
|
01/30/12
|
Valeant Pharmaceuticals to Syndicate Senior Secured Term Loan Credit Facility
|
PDF
|
|
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
|
01/30/12
|
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
|
PDF
|
|
Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash
|
01/17/12
|
Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash
|
PDF
|
|
Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
|
01/06/12
|
Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
|
PDF
|